Drug profile · INN
gonadorelin acetate
LUTREPULSE KIT
gonadorelin acetate (LUTREPULSE KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — gonadorelin acetate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
gonadorelin acetate (LUTREPULSE KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is gonadorelin acetate?
gonadorelin acetate (LUTREPULSE KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gonadorelin acetate?
LUTREPULSE KIT is a marketed brand name for gonadorelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gonadorelin acetate?
gonadorelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.